Literature DB >> 12042672

XRCC1 genetic polymorphism and breast cancer risk.

Sook-Un Kim1, Sue Kyung Park, Keun-Young Yoo, Kyung-Sik Yoon, Ji Yeob Choi, Jeong-Sun Seo, Woong-Yong Park, Ju-Han Kim, Dong-Young Noh, Se-Hyun Ahn, Kuk-Jin Choe, Paul T Strickland, Ari Hirvonen, Daehee Kang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12042672     DOI： 10.1097/00008571-200206000-00010

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN： 0960-314X


× No keyword cloud information.
  19 in total

Review 1.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

2.  First survey of the two polymorphisms (Arg194Trp and Arg399Gln) in XRCC1 gene in four Afghanistan populations and comparison with worldwide data.

Authors:  Khyber Saify; Iraj Saadat; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2013-05-22       Impact factor: 2.316

3.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

4.  Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study.

Authors:  Alexandra S Shadrina; Natalia A Ermolenko; Uljana A Boyarskikh; Tatiana V Sinkina; Alexandr F Lazarev; Valentina D Petrova; Maxim L Filipenko
Journal:  Clin Exp Med       Date:  2014-12-24       Impact factor: 3.984

5.  Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients.

Authors:  Yousry Mostafa Hussien; Amal F Gharib; Hanan A Awad; Rehab A Karam; Wael H Elsawy
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

6.  Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study.

Authors:  Tao Yuan; Shaoli Deng; Hongming Liu; Menggang Liu; Ping Chen
Journal:  Exp Ther Med       Date:  2012-05-17       Impact factor: 2.447

7.  XRCC1 Arg399Gln polymorphism is not associated with breast cancer in Chinese.

Authors:  Shuren Guo; Xiaohuan Mao; Liang Ming
Journal:  Int J Clin Exp Med       Date:  2015-07-15

8.  Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran).

Authors:  Parisa Mohamadynejad; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2007-09-14       Impact factor: 2.316

9.  Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.

Authors:  Volga S Syamala; Vani Syamala; Hariharan Sreedharan; Praveenkumar B Raveendran; Ratheesan Kuttan; Ravindran Ankathil
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

10.  Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.

Authors:  Alice J Sigurdson; Michael Hauptmann; Nilanjan Chatterjee; Bruce H Alexander; Michele Morin Doody; Joni L Rutter; Jeffery P Struewing
Journal:  BMC Cancer       Date:  2004-03-12       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.